We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Brightest X-Ray Machine Probes Molecules

By LabMedica International staff writers
Posted on 17 Jun 2010
The brightest X-ray machine in the world has been designed for the energies at which it operates--with photon energies in the "hard X-ray” region and very high beam intensities of 1,018 W/cm2. More...
At these energies, the machine can serve as an extraordinary microscope for viewing matter at the scale of atoms, and biologists, chemists, and physicists have been eager to do precisely that. The technology also acts like a knife since it can peel electrons away from the parent atoms and molecules, even those huddling very close to the nucleus.

The Stanford [University] Linear Accelerator Center (SLAC; Stanford, CA, USA), long the preserve of particle physics, is also a major laboratory for conducting experiments in fields like biology and medicine. The electron acceleration equipment has been adapted over the past few years to create something known as the Linac Coherent Light Source (LCLS), which produces short X-ray pulses millions of times brighter than those currently created by other instruments.

Becoming operational in the fall of 2009, the first experimental results from the LCLS are starting to appear at scientific meetings. Dr. Li Fang of Western Michigan University (Kalamazoo, MI, USA) reported on May 21, 2010, at the 2010 Conference on Lasers and Electro-Optics/Quantum Electronics and Laser Science Conference (CLEO/QELS), held in San Jose, CA, USA, on how the powerful LCLS X-rays can be used to strip electrons away from a nitrogen molecule. He noted that in the extreme case, nitrogen atoms were detected from which all of the electrons had been removed. This causes the molecule to quickly dissociate. The plucked electrons, which nearby detectors can spot and measure, allow researchers to calculate the binding energy within the original molecule.

In future studies, more such measurements should give investigators a more accurate assessment of large molecules, in particular, biomolecules.

At the 2010 CLEO/QELS, researchers from around the world presented the latest breakthroughs in electro-optics, innovative developments in laser science, and commercial applications in photonics.

Related Links:

Stanford Linear Accelerator Center
Western Michigan University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.